ArticleCureus2025
Paroxysmal Sympathetic Hyperactivity Complicated by Rhabdomyolysis and Acute Kidney Injury Following Spontaneous Pontine Hemorrhage.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paroxysmal sympathetic hyperactivity (PSH) is a potentially life-threatening clinical syndrome characterized by sudden, episodic increases in sympathetic nervous system activity. While commonly described after traumatic brain injury, it is a rare and under-recognized complication of intracerebral hemorrhage (ICH). Diagnosis is challenging in the acute setting due to its nonspecific presentation and constellation of symptoms. The pathophysiology remains poorly understood, and no standardized diagnosis or treatment guidelines exist. We describe a case of a 50-year-old male patient with spontaneous pontine ICH who developed PSH within a week of admission, with hyperthermia, hypertension, tachycardia, and dystonic posturing. Despite multimodal therapy with bromocriptine, baclofen and clobazam, the patient developed complications of rhabdomyolysis likely from drug-refractory paroxysmal rigidity and acute kidney injury requiring dialysis. This case highlights the diagnostic and therapeutic challenges of PSH in neurocritical care, underscoring the necessity of heightened clinical suspicion, exclusion of mimics, and early individualized treatment to optimise outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.